489 related articles for article (PubMed ID: 26210507)
21. Quantitative structure-activity relationships for the in vitro antimycobacterial activity of pyrazinoic acid esters.
Bergmann KE; Cynamon MH; Welch JT
J Med Chem; 1996 Aug; 39(17):3394-400. PubMed ID: 8765523
[TBL] [Abstract][Full Text] [Related]
22. Co(II) and Cu(II) pyrophosphate complexes have selectivity and potency against Mycobacteria including Mycobacterium tuberculosis.
Hoffman AE; DeStefano M; Shoen C; Gopinath K; Warner DF; Cynamon M; Doyle RP
Eur J Med Chem; 2013; 70():589-93. PubMed ID: 24211634
[TBL] [Abstract][Full Text] [Related]
23. meso-Dihydroguaiaretic acid derivatives with antibacterial and antimycobacterial activity.
Reyes-Melo K; García A; Romo-Mancillas A; Garza-González E; Rivas-Galindo VM; Miranda LD; Vargas-Villarreal J; Favela-Hernández JMJ; Camacho-Corona MDR
Bioorg Med Chem; 2017 Oct; 25(20):5247-5259. PubMed ID: 28844400
[TBL] [Abstract][Full Text] [Related]
24. Naphthoquinones isolated from Diospyros anisandra exhibit potent activity against pan-resistant first-line drugs Mycobacterium tuberculosis strains.
Uc-Cachón AH; Borges-Argáez R; Said-Fernández S; Vargas-Villarreal J; González-Salazar F; Méndez-González M; Cáceres-Farfán M; Molina-Salinas GM
Pulm Pharmacol Ther; 2014 Feb; 27(1):114-20. PubMed ID: 23968826
[TBL] [Abstract][Full Text] [Related]
25. Antimycobacterial activity of basic ethyl esters of alkoxy-substituted phenylcarbamic acids.
Waisser K; Drazková K; Cizmárik J; Kaustová J
Folia Microbiol (Praha); 2003; 48(1):45-50. PubMed ID: 12744075
[TBL] [Abstract][Full Text] [Related]
26. Synthesis and antimycobacterial activities of ring-substituted quinolinecarboxylic acid/ester analogues. Part 1.
Vaitilingam B; Nayyar A; Palde PB; Monga V; Jain R; Kaur S; Singh PP
Bioorg Med Chem; 2004 Aug; 12(15):4179-88. PubMed ID: 15246094
[TBL] [Abstract][Full Text] [Related]
27. Antimycobacterial N-pyridinylsalicylamides, isosters of salicylamides.
Waisser K; Drazková K; Kunes J; Klimesová V; Kaustová J
Farmaco; 2004 Aug; 59(8):615-25. PubMed ID: 15262531
[TBL] [Abstract][Full Text] [Related]
28. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
29. [Relation between chemical structure and antimycobacterial activity against atypical strains. XIII. Thiosalicylanilides].
Waisser K; Kubicová L; Gregor J; Budová J; Andrlová A; Drsata J; Odlerová Z
Ceska Slov Farm; 1998 Mar; 47(2):84-6. PubMed ID: 9650366
[TBL] [Abstract][Full Text] [Related]
30. Antimycobacterial activity of Citrullus colocynthis (L.) Schrad. against drug sensitive and drug resistant Mycobacterium tuberculosis and MOTT clinical isolates.
Mehta A; Srivastva G; Kachhwaha S; Sharma M; Kothari SL
J Ethnopharmacol; 2013 Aug; 149(1):195-200. PubMed ID: 23816500
[TBL] [Abstract][Full Text] [Related]
31. Antistaphylococcal activity of novel salicylanilide derivatives.
Mollaghan A; Vinsova J; Imramovsky A; Cotter L; Lucey B; O'Mahony J; Costelloe A; Coffey A
Curr Drug Discov Technol; 2012 Mar; 9(1):39-47. PubMed ID: 21644919
[TBL] [Abstract][Full Text] [Related]
32. Synthesis, antimycobacterial and antibacterial activity of fluoroquinolone derivatives containing an 3-alkoxyimino-4-(cyclopropylanimo)methylpyrrolidine moiety.
Zhang T; Shen W; Liu M; Zhang R; Wang M; Li L; Wang B; Guo H; Lu Y
Eur J Med Chem; 2015 Nov; 104():73-85. PubMed ID: 26435513
[TBL] [Abstract][Full Text] [Related]
33. Salicylanilide carbamates: Promising antibacterial agents with high in vitro activity against methicillin-resistant Staphylococcus aureus (MRSA).
Zadrazilova I; Pospisilova S; Masarikova M; Imramovsky A; Ferriz JM; Vinsova J; Cizek A; Jampilek J
Eur J Pharm Sci; 2015 Sep; 77():197-207. PubMed ID: 26079401
[TBL] [Abstract][Full Text] [Related]
34. Novel 1-(4-substituted benzylidene)-4-(1-(substituted methyl)-2,3-dioxoindolin-5-yl)semicarbazide derivatives for use against Mycobacterium tuberculosis H37Rv (ATCC 27294) and MDR-TB strain.
Raja S; Prakash CR
Arch Pharm Res; 2013 Apr; 36(4):411-22. PubMed ID: 23440582
[TBL] [Abstract][Full Text] [Related]
35. Synthesis, Bioactivity Evaluation, and Toxicity Assessment of Novel Salicylanilide Ester Derivatives as Cercaricides against Schistosoma japonicum and Molluscicides against Oncomelania hupensis.
Wang W; Qin Z; Zhu D; Wei Y; Li S; Duan L
Antimicrob Agents Chemother; 2016 Jan; 60(1):323-31. PubMed ID: 26503661
[TBL] [Abstract][Full Text] [Related]
36. Synthesis and structure-activity relationship of new chalcone linked 5-phenyl-3-isoxazolecarboxylic acid methyl esters potentially active against drug resistant Mycobacterium tuberculosis.
Sahoo SK; Rani B; Gaikwad NB; Ahmad MN; Kaul G; Shukla M; Nanduri S; Dasgupta A; Chopra S; Yaddanapudi VM
Eur J Med Chem; 2021 Oct; 222():113580. PubMed ID: 34116324
[TBL] [Abstract][Full Text] [Related]
37. Study of Biological Activities and ADMET-Related Properties of Salicylanilide-Based Peptidomimetics.
Pindjakova D; Pilarova E; Pauk K; Michnova H; Hosek J; Magar P; Cizek A; Imramovsky A; Jampilek J
Int J Mol Sci; 2022 Oct; 23(19):. PubMed ID: 36232947
[TBL] [Abstract][Full Text] [Related]
38. Anti-mycobacterial activity of plumericin and isoplumericin against MDR Mycobacterium tuberculosis.
Kumar P; Singh A; Sharma U; Singh D; Dobhal MP; Singh S
Pulm Pharmacol Ther; 2013 Jun; 26(3):332-5. PubMed ID: 23333815
[TBL] [Abstract][Full Text] [Related]
39. In vitro and ex vivo activity of new derivatives of acetohydroxyacid synthase inhibitors against Mycobacterium tuberculosis and non-tuberculous mycobacteria.
Sohn H; Lee KS; Ko YK; Ryu JW; Woo JC; Koo DW; Shin SJ; Ahn SJ; Shin AR; Song CH; Jo EK; Park JK; Kim HJ
Int J Antimicrob Agents; 2008 Jun; 31(6):567-71. PubMed ID: 18337064
[TBL] [Abstract][Full Text] [Related]
40. Activity of Rifabutin and Hemi-synthetic Derivatives Against Mycobacterium abscessus.
Ramis IB; Figueiredo R; Ramos DF; Halicki PCB; von Groll A; Viveiros M; do Ceu Costa M; da Silva PEA
Med Chem; 2018; 14(4):394-399. PubMed ID: 29205119
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
